Cempra Inc (NASDAQ:CEMP)

32.00
Delayed Data
As of Mar 27
 +1.01 / +3.26%
Today’s Change
8.10
Today|||52-Week Range
41.63
+36.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$1.3B

Company Description

Cempra, Inc. is a clinical-stage pharmaceutical company. It focuses on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. The company intends to utilize its series of proprietary lead compounds from its novel macrolide library for uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. It has two antibiotic candidates: Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC.

Contact Information

Cempra, Inc.
Building Two Quadrangle
Chapel Hill North Carolina 27517-8149
P:(919) 313-6601
Investor Relations:

Employees

Shareholders

Individual stakeholders28.95%
Mutual fund holders26.74%
Other institutional19.35%

Top Executives

Prabhavathi B. FernandesPresident, Chief Executive Officer & Director
Mark W. HahnChief Financial Officer & Executive Vice President
David OldachChief Medical Officer
David S. MooreChief Commercial Officer & Executive VP
David PereiraSenior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account